Investor mix
12 investors on record; lead investors include 4Bio Capital, UPMC, Northpond Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Other / undisclosed | 6 | 50% |
Developer of gene therapies for rare diseases
12 investors on record; lead investors include 4Bio Capital, UPMC, Northpond Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 50% |
| Other / undisclosed | 6 | 50% |